Form 4: Edwards Lifesciences Executive Exercises Performance Rights, Sells Shares to Cover Taxes

Donald E. Bobo Jr., a CVP at Edwards Lifesciences, exercised performance rights and sold shares to cover tax obligations.

Summary

• On May 3, 2024, Donald E. Bobo Jr., CVP of Strategy/Corporate Development at Edwards Lifesciences Corp, engaged in transactions involving the company's common stock.
• Bobo disposed of 479 shares of common stock at a price of $85.06 to cover tax obligations.
• On May 4, 2024, Bobo exercised 5,855 performance rights, acquiring 5,855 shares of common stock at a price of $0.
• Bobo then disposed of 3,475 shares at $85.25 to cover taxes related to the performance rights exercise.
• Following these transactions, Bobo directly owns 41,668.7184 shares of common stock.
• Bobo also indirectly owns 38,615.0363 shares through a 401(k) plan and 135,152 shares through a trust.

Sentiment

Score: 5

Explanation: The document reflects routine executive stock transactions related to compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation and tax planning. The exercise of performance rights indicates that the executive has met certain performance goals set by the company.

Comparison to Industry Standards

• Executive compensation practices, including the use of performance-based equity awards, are common across the medical device industry.
• Companies like Medtronic, Abbott, and Boston Scientific also utilize similar equity-based compensation plans to incentivize and retain key executives.
• The vesting and exercise of these awards are typically tied to company performance metrics and are disclosed through SEC filings like Form 4.

Key Dates